Mad cow disease test in development - New tests - Caprion Pharmaceuticals Inc - OrthoClinical Diagnostics Inc - Brief Article

Medical Laboratory Observer, Feb, 2002

> A new licensing agreement between OrthoClinical Diagnostics Inc, (OCD) and Caprion Pharmaceuticals Inc. focuses on the development of a human blood test for variant Creutzfield-Jacob disease (vCJD), the human equivalent of mad cow disease. OCD, a Johnson & Johnson Co. based in Raritan, NJ, has been collaborating with Montreal-based Caprion on their prion technologies, including their unique monoclonal antibodies for detection of the agent responsible for vCJD.

COPYRIGHT 2002 Nelson Publishing
COPYRIGHT 2002 Gale Group
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here

Content provided in partnership with Thompson Gale